NOVARTIS AG

Forecast & Rating11 analysts currently cover NOVARTIS AG, with about 45.5% giving a positive rating — meaning they expect the stock to rise. The average price target is $157.10, about 2.0% downside from the current price of $160.25. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 66.3% of past price targets were eventually met, which adds credibility. For you, this means institutional views on NOVARTIS AG are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Nov 12, 2026; for reference only and not investment advice.